Detalhe da pesquisa
1.
A MXI1-NUTM1 fusion protein with MYC-like activity suggests a novel oncogenic mechanism in a subset of NUTM1-rearranged tumors.
Lab Invest;
101(1): 26-37, 2021 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32873880
2.
Copy number analysis of ductal carcinoma in situ with and without recurrence.
Mod Pathol;
28(9): 1174-84, 2015 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26321097
3.
Exome sequencing identifies rare deleterious mutations in DNA repair genes FANCC and BLM as potential breast cancer susceptibility alleles.
PLoS Genet;
8(9): e1002894, 2012 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23028338
4.
Analysis of RAD51C germline mutations in high-risk breast and ovarian cancer families and ovarian cancer patients.
Hum Mutat;
33(1): 95-9, 2012 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21990120
5.
Analysis of KLLN as a high-penetrance breast cancer predisposition gene.
Breast Cancer Res Treat;
134(2): 543-7, 2012 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-22580995
6.
Analysis of the mitogen-activated protein kinase kinase 4 (MAP2K4) tumor suppressor gene in ovarian cancer.
BMC Cancer;
11: 173, 2011 May 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21575258
7.
Frequent somatic mutations of GATA3 in non-BRCA1/BRCA2 familial breast tumors, but not in BRCA1-, BRCA2- or sporadic breast tumors.
Breast Cancer Res Treat;
119(2): 491-6, 2010 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19189213
8.
Improved next-generation sequencing pre-capture library yields and sequencing parameters using on-bead PCR.
Biotechniques;
68(1): 48-51, 2020 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31825238
9.
Genetic analysis of cancer-implicated MicroRNA in ovarian cancer.
Clin Cancer Res;
14(22): 7246-50, 2008 Nov 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19010840
10.
Profound MEK inhibitor response in a cutaneous melanoma harboring a GOLGA4-RAF1 fusion.
J Clin Invest;
129(5): 1940-1945, 2019 05 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30835257
11.
Breast cancer risk and the BRCA1 interacting protein CTIP.
Breast Cancer Res Treat;
112(2): 351-2, 2008 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-18095152
12.
High-resolution single nucleotide polymorphism array analysis of epithelial ovarian cancer reveals numerous microdeletions and amplifications.
Clin Cancer Res;
13(16): 4731-9, 2007 Aug 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17699850
13.
SDH-deficient renal cell carcinoma associated with biallelic mutation in succinate dehydrogenase A: comprehensive genetic profiling and its relation to therapy response.
NPJ Precis Oncol;
2: 9, 2018.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29872718
14.
Genetic and epigenetic analysis of the TIMP-3 gene in ovarian cancer.
Cancer Lett;
247(1): 91-7, 2007 Mar 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-16644110
15.
Genetic and epigenetic analysis of the putative tumor suppressor km23 in primary ovarian, breast, and colorectal cancers.
Clin Cancer Res;
12(12): 3713-5, 2006 Jun 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-16778097
16.
No association of the MDM2 SNP309 polymorphism with risk of breast or ovarian cancer.
Cancer Lett;
240(2): 195-7, 2006 Aug 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-16239061
17.
Mutation and expression analysis of LZTS1 in ovarian cancer.
Cancer Lett;
233(1): 151-7, 2006 Feb 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-15876481
18.
Mutation of the PIK3CA gene in ovarian and breast cancer.
Cancer Res;
64(21): 7678-81, 2004 Nov 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-15520168
19.
Differential hypermethylation of SOCS genes in ovarian and breast carcinomas.
Oncogene;
23(46): 7726-33, 2004 Oct 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-15361843
20.
EDD, the human orthologue of the hyperplastic discs tumour suppressor gene, is amplified and overexpressed in cancer.
Oncogene;
22(32): 5070-81, 2003 Aug 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-12902990